How to assess, diagnose, refer and treat adult obstructive sleep apnoea: a commentary on the choices

The Medical Journal of Australia
Darren R MansfieldR Doug McEvoy

Abstract

Obstructive sleep apnoea (OSA) determined by polysomnography is highly prevalent, affecting about 25% of men and 10% of women in the United States, although most have few or no symptoms. Symptomatic moderate to severe OSA has major health implications related to daytime sleepiness, such as increased accidents, altered mood and loss of productivity in the workplace. Severe OSA may increase the risk of cardiovascular disease independent of daytime sleepiness. A major challenge is to correctly identify, from the large community pool of disease, people with symptoms and those at risk of long-term complications. For treatment plans to achieve quality patient outcomes, clinicians must have a clear understanding of patients' symptoms and their motivations for presentation, and be knowledgeable about the evidence surrounding the health risks of OSA and the relative merits of the various diagnostic and treatment options available. The diagnosis of OSA represents a teachable moment to target adverse lifestyle factors such as excessive weight, excessive alcohol consumption and smoking, which may be contributing to OSA and long-term cardiometabolic risk. OSA assessment and management has traditionally involved specialist referral and in-la...Continue Reading

References

Jul 1, 1988·Chest·C GuilleminaultG Nino-Murcia
Apr 29, 1993·The New England Journal of Medicine·T YoungS Badr
Oct 3, 1999·Annals of Internal Medicine·N C NetzerK P Strohl
May 11, 2000·The New England Journal of Medicine·P E PeppardJ Skatrud
Apr 6, 2002·Journal of Clinical and Experimental Neuropsychology·Cynthia F SalorioMatthew L Uhles
Mar 20, 2003·Accident; Analysis and Prevention·Jane C StuttsBradley V Vaughn
May 6, 2005·Sleep & Breathing = Schlaf & Atmung·Masroor MustafaKingman Strohl
Jun 9, 2005·The Journal of Clinical Endocrinology and Metabolism·E O BixlerA Kales
Feb 6, 2008·Proceedings of the American Thoracic Society·Terri E Weaver, Ronald R Grunstein
Apr 24, 2008·Anesthesiology·Frances ChungColin M Shapiro
Jan 13, 2009·American Journal of Respiratory and Critical Care Medicine·Nick A AnticR Doug McEvoy
Aug 19, 2009·PLoS Medicine·Naresh M PunjabiJonathan M Samet
Jun 16, 2010·Journal of Sleep Research·Kelly L ShepherdPeter R Eastwood
Jun 22, 2010·Journal of Sleep Research·Angela J Campbell, Alister M Neill
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Samuel T KunaCharles W Atwood
Sep 20, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Xia WangFang Pan
Nov 3, 2012·Australian Health Review : a Publication of the Australian Hospital Association·Robert J AdamsR Douglas McEvoy
Feb 2, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Stuart G MacKaySamuel Robinson
Feb 16, 2013·American Journal of Respiratory and Critical Care Medicine·Craig L PhillipsPeter A Cistulli
Feb 26, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ching Li Chai-CoetzerR Doug McEvoy
Mar 14, 2013·JAMA : the Journal of the American Medical Association·Ching Li Chai-CoetzerR Doug McEvoy

❮ Previous
Next ❯

Citations

Nov 26, 2015·Sleep Medicine Reviews·Jennifer N Miller, Ann M Berger
Apr 21, 2017·NPJ Primary Care Respiratory Medicine·Michael J EptonMichael C Hlavac
Feb 18, 2017·Breathe·Monique SuárezJosep M Montserrat
Feb 20, 2021·Research in Social & Administrative Pharmacy : RSAP·Mariam M BashetiBandana Saini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.